Surgery for Obstructed Gastric Carcinoma

Condition(s) studied

Investigational drug(s) / intervention(s)

palliative gastric resection: distal, subtotal or total gastrectomy with gastro-jejunostomy or eosphago-jejunostomy will be done

palliative bypass: palliative gastro-jejunostomy or eosphago-jejunostomy will be done

Study summary

The goal of this clinical trial is to find the best treatment for obstructed gastric carcinoma in gastric cancer patients. It will include all patients with obstructed gastric cancer with different ages and sex who consented to share in the trial. The main question is what is the better for management for obstructed gastric cancer; palliative resection or palliative bypass? We hypothesized that resection is better. patients will be divided into two groups. the primary outcome measure will be the relief of obstruction

Eligibility

Primary outcome measure(s)

• upper gastrointestinal symptoms — from one day to two weeks after surgery
  upper gastrointestinal symptoms will be evaluated after surgery by Rhodes Index questionnaire. It is a validated, self-report instrument used to measure the intensity, frequency, and distress of upper gastrointestinal symptoms. The scale measures three main areas: nausea (frequency, duration, distress), vomiting (amount, frequency, distress), and retching (frequency, distress). It utilizes a 5-point Likert scale (0-4) to quantify the severity of these symptoms. 0 is the least amount of distress and 4 is the most distress.

Trial sites (1)

More Zagazig University trials in Egypt

Other trials for the same condition